Natural products of plant origin against COVID-19
DOI:
https://doi.org/10.29076/issn.2528-7737vol15iss40.2022pp52-65pKeywords:
COVID-19, Natural pruducts, Phytotherapy, Medicinal plantsAbstract
Covid-19 has become a global public health problem. The use of natural products and in particular of medicinal plants, turns out to be a therapeutic tool for the treatment of the disease and its corresponding symptoms. The review that is presented below, after a search in databases of scientific rigor, has aimed to identify natural products of plant origin that can be used, for preventive purposes or as complementary therapies, against said viral infection. The evidence shows that, although there are still not enough clinical trials to define the use of certain plant resources, most authors are inclined to suggest those plants that have shown, by previous studies, potentialities including: antiviral, mucolytic, anti-inflammatory, immunomodulatory, immunostimulants, mucoprotective, antitussive, expectorant, bronchodilator and hepatoprotective activities. It should be noted that the largest number of scientific publications related to the subject refer to the traditional natural medicine of China and India. Although scientists worldwide have dedicated efforts to find preventive drugs or treatments for this condition, more reliable scientific evidence is still needed (standardized clinical trials) that can verify the real efficacy and safety of some medicinal plants or secondary metabolites derived from them.
Downloads
References
Abbass, H. S. (2020). Eucalyptus essential oil; an off-label use to protect the world from covid-19 pandemic: review-based hypotheses. Universal J Pharm Res, 5(4), 57-60. DOI: 10.22270/ujpr.v5i4.440.
Akbas, M. N. y Akcakaya, A. (2020). COVID-19 and Phytotherapy. Bezmialem Science, 8(4), 428-438. DOI: 10.14235/bas.galenos.2020.4962
Ali, I. y Alharbi, O. M. L. (2020). COVID-19: Disease, management, treatment, and social impact. Sci Total Environ, 728:138861. DOI: 10.1016/j.scitotenv.2020.138861.
Alonso, M. J. y Brizuela L. A. (2021). Indicación farmacéutica en gripe y resfriado en el contexto del COVID-19. Pharmaceutical Care España, 23(1), 40–72. https://www.pharmcareesp.com/index.php/PharmaCARE/article/view/629
Álvarez, A. C. (2020). La Historia del COVID 19 en tiempos del Coronavirus. Un ensayo inconcluso. 11. https://fh.mdp.edu.ar/revistas/index.php/pasadoabierto
Avello, M. y Cisternas I. (2010). Fitoterapia, sus orígenes, características y situación en Chile. Rev Med Chile; 138: 1288-1293
Bailly, C. y Vergoten, G. (2020). Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome? Pharmacology & therapeutics, 214, 107618. DOI: 10.1016/j.pharmthera.2020.107618.
Bellavite, P. y Donzelli, A. (2020). Hesperidin and SARS-CoV-2: new light on the healthy function of citrus fruits. Antioxidants, 9(8), 742. DOI: 10.3390/antiox9080742.
Boozari, M. y Hosseinzadeh, H. (2021). Natural products for COVID‐19 prevention and treatment regarding to previous coronavirus infections and novel studies. Phytotherapy Research, 35(2), 864-876. DOI: 10.1002/ptr.6873.
Cañigueral, S, Vila y R. (2003). La Fitoterapia racional. En: Vanaclocha B, Cañigueral S (Eds.) Fitoterapia: Vademécum de prescripción. 4ª Ed. Barcelona: Editorial Masson:15-27.
Cañigueral, S. y Vila, R. (2005). La Fitoterapia como herramienta terapéutica. Ginecología y Obstetricia Clínica, 6(1):43-51.
Cheng, P. W., Ng, L. T., Chiang, L. C. y Lin, C. C. (2006). Antiviral effects of saikosaponins on human coronavirus 229E in vitro. Clinical and Experimental Pharmacology and Physiology, 33(7), 612-616. DOI: 10.1111/j.1440-1681.2006.04415.x.
Cho, J. K., Curtis-Long, M. J., Lee, K. H., Kim, D. W., Ryu, H. W., Yuk, H. J. y Park, K. H. (2013). Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia tomentosa. Bioorganic & medicinal chemistry, 21(11), 3051-3057. DOI: 10.1016/j.bmc.2013.03.027.
Collective, K. (2021). Experiencing Covid-19 in the Ecuadorian Amazon rainforest. Interactions, 28(2), 10-13.
García, E. C. y Solís, I. M. (Eds.). (2021). Manual de fitoterapia. Elsevier Health Sciences.
Garrido, I, Liberal, R. y Macedo, G. (2020). Review article: COVID-19 and liver disease-what we know on 1st May 2020. Aliment Pharmacol Ther, 52, 267-75. DOI: 10.1111/apt.15813.
Ge, X. Y., Li, J. L., Yang, X. L., Chmura, A. A., Zhu, G., Epstein, J. H, Mazet, J.K., Ben, H., Wei, Z., Cheng, P., Yu-I, Z., Chu-Ming, L., Bing, T., Ning, W., Yan, Z., Gary, C. Shu-Yo, Z., Lin-Fa, W., Daszak, P. y Shi, Z. L. (2013). Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature, 503(7477), 535-538. https://doi.org/10.1038/nature12711
Guan, W. J., Ni, Z. Y., Hu, Y., Liang, W. H., Ou, C. Q., He, J. X., Shan, C., Lei, D.S., Hui, B., Du, L., Li, G., Zeng, K., Yuen, R., Chen, C., Tang, T., Wang, P., Xiang, S., Li, J., Liang, Y., Peng, L., wei, Y., Liu, Y., Hu, P., Peng, J., Wang, J., Chen, G., Li, Z., Zheng, S., Qiu, J., Luo, C., Ye, S.y Zhong, N. S. (2020). Clinical characteristics of coronavirus disease 2019 in China. New England journal of medicine, 382(18), 1708-1720. DOI: 10.1007/s11606-020-05762-w.
Guo, X. J., Thomas, P. G. (2017). New fronts emerge in the influenza cytokine storm. Semin Immunopathol, 39, 541-50. DOI: 10.1007/s00281-017-0636-y.
Ha, S. K., Park, H. Y., Eom, H., Kim, Y., y Choi, I. (2012). Narirutin fraction from citrus peels attenuates LPS-stimulated inflammatory response through inhibition of NF-κB and MAPKs activation. Food and chemical toxicology, 50(10), 3498-3504. DOI: 10.1016/j.fct.2012.07.007.
Hu, B., Zeng, L. P., Yang, X. L., Ge, X. Y., Zhang, W., Li, B., Jia-Zheng X., Xu-Rui S., Yun-Zhi Z., Ning W., Dong-Sheng L., Xiao-Shuang Z., Mei-Niang W., Daszak, P., Lin-Fa W., Jie C. y Shi, Z. L. (2017). Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus. PLoS pathogens, 13(11), e1006698. DOI: 10.1371/journal.ppat.1006698.
Huang, L., Li, H., Yuen, T. T. T., Ye, Z., Fu, Q., Sun, W., Xu, Q., Yang, Y., Fuk-Woo, J., Zhang, G., Chu, H., Qi, W., Yue, J. y Yue, J. (2020). Berbamine inhibits the infection of SARS-CoV-2 and flaviviruses by compromising TPRMLs-mediated endolysosomal trafficking of viral receptors (LDLR). Emerg Microbes Infect.,10(1), 1257–1271. DOI: 10.1080/22221751.2021.1941276
Hussain, A., Kaler, J., Tabrez, E., Tabrez, S. y Tabrez, S. S. (2020). Novel COVID-19: A comprehensive review of transmission, manifestation, and pathogenesis. Cureus, 12:e8184. DOI: 10.7759/cureus.8184
Jo, S., Kim, H., Kim, S., Shin, D. H. y Kim, M. S. (2019). Characteristics of flavonoids as potent MERS‐CoV 3C‐like protease inhibitors. Chemical biology & drug design, 94(6), 2023-2030. DOI: 10.1111/cbdd.13604.
Jo, S., Kim, S., Shin, D. H. y Kim, M. S. (2020). Inhibition of SARS-CoV 3CL protease by flavonoids. Journal of enzyme inhibition and medicinal chemistry, 35(1), 145-151. DOI: 10.1080/14756366.2019.1690480.
Keum, Y. S. y Jeong, Y. J. (2012). Development of chemical inhibitors of the SARS coronavirus: viral helicase as a potential target. Biochemical pharmacology, 84(10), 1351-1358. DOI: 10.1016/j.bcp.2012.08.012.
Kim, D. E., Min, J. S., Jang, M. S., Lee, J. Y., Shin, Y. S., Park, C. M., Song, J., Kim, H., Kim, S., Young-Hee, J. y Kwon, S. (2019). Natural bis-benzylisoquinoline alkaloids-tetrandrine, fangchinoline, and cepharanthine, inhibit human coronavirus OC43 infection of MRC-5 human lung cells. Biomolecules, 9(11), 696. DOI: 10.3390/biom9110696.
Kim, D. W., Seo, K. H., Curtis-Long, M. J., Oh, K. Y., Oh, J. W., Cho, J. K., Lee, K. y Park, K. H. (2014). Phenolic phytochemical displaying SARS-CoV papain-like protease inhibition from the seeds of Psoralea corylifolia. Journal of enzyme inhibition and medicinal chemistry, 29(1), 59-63. DOI: 10.3109/14756366.2012.753591.
Laws, M.; Surani, Y.M.; Hasan, M.M.; Chen, Y.; Jin, P.; AlAdhami, T.; Chowdhury, M.; Imran, A.; Psaltis, I.; Jamshidi, S., Nahar, K. y Rahman, K. Current Trends and Future Approaches in Small-Molecule Therapeutics for COVID-19. Curr. Med. Chem. 2020, 27, 1–19. DOI: 10.2174/0929867327666200721161840.
Liu, X., Zhang, M., He, L. y Li, Y. (2012). Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS). Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD004882.pub3.
Manzano-Santana, P. I., Tivillin, J. P. P., Chóez-Guaranda, I. A., Lucas, A. D. B. y Katherine, A. (2021). Potential bioactive compounds of medicinal plants against new Coronavirus (SARS-CoV-2): A review. Bionatura. Latin American Journal of Biotechnology and Life Sciences. 6 (1), 1653-1658. DOI: 10.21931/RB/2021.06.01.30.
Masiello, P., Novelli, M., Beffy, P. y Menegazzi, M. (2020). Can Hypericum perforatum (SJW) prevent cytokine storm in COVID‐19 patients? Phytotherapy Research. 1-3, DOI: 10.1002/ptr.6764. DOI: 10.1002/ptr.6764.
Mason, R. J. (2020). Pathogenesis of COVID-19 from a cell biology perspective. Eur Respir J, 55:2000607. DOI: 10.1183/13993003.00607-2020.
Murck, H. (2020). Symptomatic protective action of glycyrrhizin (licorice) in COVID-19 infection? Frontiers in immunology, 11, 1239. DOI: 10.3389/fimmu.2020.01239
Nguyen, T. T. H., Woo, H. J., Kang, H. K., Nguyen, V. D., Kim, Y. M., Kim, D. W., Ahn, S., Xia, Y., y Kim, D. (2012). Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris, Biotechnology letters, 34(5), 831-838. DOI: 10.1007/s10529-011-0845-8.
Organización Mundial de la Salud. (2013) . Estrategia de la OMS sobre medicina tradicional 2014-2023. Organización Mundial de la Salud. https://apps.who.int/iris/handle/10665/95008
Osorio, M. J. A., y Rodicio, L. A. B. (2021). Indicación farmacéutica en gripe y resfriado en el contexto del COVID-19. Pharmaceutical Care España, 23(1), 40-72. Recuperado a partir de https://www.pharmcareesp.com/index.php/PharmaCARE/article/view/629.
Pareja, A. y Luque, J. C. (2020). Alternativas terapéuticas farmacológicas para COVID-19. Horizonte Médico (Lima), 20(2). DOI: https://doi.org/10.24265/horizmed.2020.v20n2.13.
Park, J. Y., Ko, J. A., Kim, D. W., Kim, Y. M., Kwon, H. J., Jeong, H. J., Cha, Y., Ki, P.,Woo, L. y Ryu, Y. B. (2016). Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV. Journal of enzyme inhibition and medicinal chemistry, 31(1), 23-30. DOI: 10.3109/14756366.2014.1003215
Park, J. Y., Yuk, H. J., Ryu, H. W., Lim, S. H., Kim, K. S., Park, K. H., Young, B. R. y Lee, W. S. (2017). Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors. Journal of enzyme inhibition and medicinal chemistry, 32(1), 504-512. DOI: 10.1080/14756366.2016.1265519
Ren, J. L., Zhang, A. H. y Wang, X. J. (2020). Traditional Chinese medicine for COVID-19 treatment. Pharmacol Res, 155:104743. DOI: 10.1016/j.phrs.2020.104743
Rogosnitzky, M., Okediji, P. y Koman, I. (2020). Cepharanthine: A review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19. Pharmacological Reports, 1-8. DOI: 10.1007/s43440-020-00132-z
Rothe, C., Schunk, M., Sothmann, P., Bretzel, G., Froeschl, G., Wallrauch, C. y Hoelscher, M. (2020). Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. New England journal of medicine, 382(10), 970-971. DOI: 10.1056/NEJMc2001468
Sampangi-Ramaiah, M. H., Vishwakarma, R. y Shaanker, R. U. (2020). Molecular docking analysis of selected natural products from plants for inhibition of SARS-CoV-2 main protease. Curr. Sci, 118(7), 1087-1092.
Sapra, L., Bhardwaj, A., Azam, Z., Madhry, D., Verma, B., Rathore, S. y Srivastava, R. K. (2021). Phytotherapy for treatment of cytokine storm in COVID-19. Front Biosci (Landmark Ed), 26(5), 51-75. DOI: 10.52586/4924
Shi, Y., Wang, Y., Shao, C., Huang, J., Gan, J., Huang, X., Bucci, E., Piancetini, M., Ippolito, G.y Melino, G. (2020). COVID-19 infection: the perspectives on immune responses. Cell Death & Differentiation, 27(5), 1451-1454.
Singh, T. U, Parida, S, Lingaraju, M. C., Kesavan, M., Kumar, D. y Singh, R. K. (2020). Drug repurposing approach to fight COVID-19. Pharmacological Reports; 72, 1479–1508.
Sohail, M. N., Rasul, F., Karim, A., Kanwal, U. y Attitalla, I. H. (2011). Plant as a source of natural antiviral agents. Asian Journal of Animal and Veterinary Advances, 6(12), 1125-1152.
Sohail, M. I., Siddiqui, A., Erum, N. y Kamran, M. (2021). Phytomedicine and the COVID-19 pandemic. Phytomedicine, 693-708. DOI: 10.1016/B978-0-12-824109-7.00005-4
Song, J. W., Long, J. Y., Xie, L., Zhang, L. L., Xie, Q. X., Chen, H. J. y Li, X. F. (2020). Applications, phytochemistry, pharmacological effects, pharmacokinetics, toxicity of Scutellaria baicalensis Georgi. and its probably potential therapeutic effects on COVID-19: a review. Chinese Medicine, 15(1), 1-26.
Su, H., Yao, S., Zhao, W., Li, M., Liu, J., Shang, W., Hang, X., Changgiang, K., Kungian, Y., Hong, L., Jingshan, S., Wei, T., Zhang, Z., Jianping, Z., Hualliang, J., Fang, B., Yan, W.y Xu, Y. (2020). Discovery of baicalin and baicalein as novel, natural product inhibitors of SARS-CoV-2 3CL protease in vitro. BioRxiv. https://doi.org/10.1101/2020.04.13.038687
Tejera, E., Pérez-Castillo, Y., Toscano, G., Noboa, A. L., Ochoa-Herrera, V., Giampieri, F. y Álvarez-Suarez, J. M. (2022). Computational modeling predicts potential effects of the herbal infusion “horchata” against COVID-19. Food chemistry, 366, 130589. DOI: 10.1016/j.foodchem.2021.130589
Wu, Z. y McGoogan, J. M. (2020). Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. Journal of the American Medical Association, 323, 1239.
Yang, L., Wu, Z., Ren, X., Yang, F., He, G., Zhang, J., Dong, J., Sun, L., Zhu, Y.,Du, J., Zhang, S. y Jin, Q. (2013). Novel SARS-like betacoronaviruses in bats, China, 2011. Emerging infectious diseases, 19(6), 989.
Downloads
Published
Issue
Section
License
Authors can keep the copyright, granting the journal right of first publication. Alternatively, authors can transfer copyright to the journal, which allow authors non-commercial use of the work, including the right to place it in a file open access.
